Existing snoring therapies are either:
- Ineffective
- Require a snorer to use a device every night or
- Require invasive surgery
Zelegent aims to change that for good.
Zelegent is an EvoNexus Company
Home
Snoring is caused by airway obstruction.
Typically a soft floppy structure called the soft palate is to blame.
Learn More
An estimated 1 in 4 adults has a clinically-harmful level of snoring. Zelegent, Inc. is developing technology that should allow physicians to quickly and safely correct most cases of snoring.
Snoring is Common
Inquire About Enrolling in a Trial
A multi-center clinical trial that will evaluate the safety and efficacy of the Zelegent, Inc. procedure is being planned for several cities in the U.S. If you live in New York City, San Francisco, San Jose, Boston, or Dallas (one of the centers with a Zelegent-participating sleep-disorder otolaryngologist), and you are interested in participating in the clinical trial as a Study Subject, click on More below. Zelegent, Inc. will provide additional information in the near future.
Snoring contributes to the end of many relationships. Treating snoring leads to the repair of some of them. Snoring has a surprisingly large impact on the family unit, and therefore, on society.
Company News
Search engine
Use this form to find things you need on this siteYou can add any HTML here (admin -> Theme Options -> Promo Popup).
We suggest you create a static block and put it here using shortcode